The past few years have seen remarkable advances in the treatment of previously untreatable conditions. Most relevant to me is the approval of lecanemab for use in the UK and elsewhere to slow the progression of the disease. Early stage of Alzheimer’s disease. It’s not a cure, but it gets us closer to dementia becoming a chronic condition controlled with medications.
But although lecanemab has been hailed as a game-changer, it is not yet ready for use, and in the meantime, 55 million people are living on this drug. dementia globally. In 2050, this number will increase to 139 million. This is the world’s largest medical…